In This Section

Division for Cancer Pharmacology – Young Investigators Symposium

Tuesday April 09, 2019

4:00 pm - 6:00 pm Eastern Time (ET)

Room W206 B

DCP

Chair :

Mary-Ann Bjornsti
Univ of Alabama- Birmingham

Jack Yalowich
Ohio State University



This session will feature oral presentations by young scientists that were selected from the submitted abstracts.

Speakers

Joseph Flores-Toro - University of Florida

CCR2 Inhibition Reduces Tumor-Associated Myeloid-Derived Suppressor Cells and Unmasks an α-PD-1 Effect to Slow Tumor Progression in Checkpoint Inhibitor Resistant Gliomas

Sreedhar Reddy Suthe - Texas Tech University Health Sciences Center

RON Receptor-Targeted Antibody-Drug Conjugate Therapy Ablates Cancer Stem Cells and Induces Longterm Tumor Regressions in Preclinical Models of Triple-Negative Breast Cancer (TNBC)

Xuan Yang - Emory University

Discovery and Interrogation of New Mechanism to Control MYC Oncogene by Mitogen-Activated Protein Kinase Kinase 3

Shreoshi Pal Choudhuri - UT Southwestern Medical Center

Pancreatic Ductal Adenocarcinoma Tumor Suppressors Rgs8-16

Hilary Nicholson - Dana-Farber Cancer Institute / Harvard Medical School

Loss of CDK4/6 Activity Is Synthetic Lethal with VHL Inactivation in Clear Cell Renal Cell Carcinoma

Reiya Hayden - University of Kentucky

Mithramycin Analogues Disrupt ETS Transcription Tfactor DNA Binding

Sharon Garrott - University of Virginia

The Mechanism of Inhibition of the Undrugged Oncogenic Phosphatase PTP4A3 by a Novel Small Molecule JMS-053

Last Updated: August 15, 2019
Key Dates
April 6

ASPET Business Meeting and Awards Presentation

April 6-9

ASPET Annual Meeting at EB 2019